158 related articles for article (PubMed ID: 15241836)
1. Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia.
Burns CP; Halabi S; Clamon G; Kaplan E; Hohl RJ; Atkins JN; Schwartz MA; Wagner BA; Paskett E
Cancer; 2004 Jul; 101(2):370-8. PubMed ID: 15241836
[TBL] [Abstract][Full Text] [Related]
2. Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473.
Burns CP; Halabi S; Clamon GH; Hars V; Wagner BA; Hohl RJ; Lester E; Kirshner JJ; Vinciguerra V; Paskett E
Clin Cancer Res; 1999 Dec; 5(12):3942-7. PubMed ID: 10632323
[TBL] [Abstract][Full Text] [Related]
3. Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer.
Cerchietti LC; Navigante AH; Castro MA
Nutr Cancer; 2007; 59(1):14-20. PubMed ID: 17927497
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia: a Cancer and Leukemia Group B study.
Laviano A; Muscaritoli M; Rossi-Fanelli F
Cancer; 2005 Feb; 103(3):651-2. PubMed ID: 15578655
[No Abstract] [Full Text] [Related]
5. Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: a randomized pilot study.
Persson C; Glimelius B; Rönnelid J; Nygren P
Nutrition; 2005 Feb; 21(2):170-8. PubMed ID: 15723745
[TBL] [Abstract][Full Text] [Related]
6. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.
Jatoi A; Rowland K; Loprinzi CL; Sloan JA; Dakhil SR; MacDonald N; Gagnon B; Novotny PJ; Mailliard JA; Bushey TI; Nair S; Christensen B;
J Clin Oncol; 2004 Jun; 22(12):2469-76. PubMed ID: 15197210
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the liver export protein synthetic response to feeding by an n-3 fatty-acid-enriched nutritional supplement is associated with anabolism in cachectic cancer patients.
Barber MD; Preston T; McMillan DC; Slater C; Ross JA; Fearon KC
Clin Sci (Lond); 2004 Apr; 106(4):359-64. PubMed ID: 14624668
[TBL] [Abstract][Full Text] [Related]
8. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
Young GS; Conquer JA; Thomas R
Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
[TBL] [Abstract][Full Text] [Related]
9. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer.
Barber MD; Ross JA; Voss AC; Tisdale MJ; Fearon KC
Br J Cancer; 1999 Sep; 81(1):80-6. PubMed ID: 10487616
[TBL] [Abstract][Full Text] [Related]
10. Dietary supplementation with n-3-fatty acids in patients with pancreatic cancer and cachexia: marine phospholipids versus fish oil - a randomized controlled double-blind trial.
Werner K; Küllenberg de Gaudry D; Taylor LA; Keck T; Unger C; Hopt UT; Massing U
Lipids Health Dis; 2017 Jun; 16(1):104. PubMed ID: 28578704
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid profile and oxidative stability of pork as influenced by duration and time of dietary linseed or fish oil supplementation.
Haak L; De Smet S; Fremaut D; Van Walleghem K; Raes K
J Anim Sci; 2008 Jun; 86(6):1418-25. PubMed ID: 18310496
[TBL] [Abstract][Full Text] [Related]
12. The use of a protein and energy dense eicosapentaenoic acid containing supplement for malignancy-related weight loss in children.
Bayram I; Erbey F; Celik N; Nelson JL; Tanyeli A
Pediatr Blood Cancer; 2009 May; 52(5):571-4. PubMed ID: 19090549
[TBL] [Abstract][Full Text] [Related]
13. Fish oil supplementation in cancer patients. Capsules or nutritional drink supplements? A controlled study of compliance.
Schmidt N; Møller G; Bæksgaard L; Østerlind K; Stark KD; Lauritzen L; Andersen JR
Clin Nutr ESPEN; 2020 Feb; 35():63-68. PubMed ID: 31987122
[TBL] [Abstract][Full Text] [Related]
14. Effect of fish oil supplementation on quality of life in a general population of older Dutch subjects: a randomized, double-blind, placebo-controlled trial.
van de Rest O; Geleijnse JM; Kok FJ; van Staveren WA; Olderikkert MG; Beekman AT; de Groot LC
J Am Geriatr Soc; 2009 Aug; 57(8):1481-6. PubMed ID: 19549020
[TBL] [Abstract][Full Text] [Related]
15. Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia.
Barber MD; Fearon KC; Tisdale MJ; McMillan DC; Ross JA
Nutr Cancer; 2001; 40(2):118-24. PubMed ID: 11962246
[TBL] [Abstract][Full Text] [Related]
16. Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state.
Jellema A; Plat J; Mensink RP
Eur J Clin Invest; 2004 Nov; 34(11):766-73. PubMed ID: 15530150
[TBL] [Abstract][Full Text] [Related]
17. Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia.
Wohl DA; Tien HC; Busby M; Cunningham C; Macintosh B; Napravnik S; Danan E; Donovan K; Hossenipour M; Simpson RJ
Clin Infect Dis; 2005 Nov; 41(10):1498-504. PubMed ID: 16231263
[TBL] [Abstract][Full Text] [Related]
18. Tolerability of omega-3 fatty acid supplements in perinatal women.
Freeman MP; Sinha P
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):203-8. PubMed ID: 17981449
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer's disease: the omega-3 Alzheimer's disease study.
Irving GF; Freund-Levi Y; Eriksdotter-Jönhagen M; Basun H; Brismar K; Hjorth E; Palmblad J; Vessby B; Vedin I; Wahlund LO; Cederholm T
J Am Geriatr Soc; 2009 Jan; 57(1):11-7. PubMed ID: 19054188
[TBL] [Abstract][Full Text] [Related]
20. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.
; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T
J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
